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Abstract Phospholipase D (PLD) has been proposed to play a
key role in the signal transduction of cellular responses to various
extracellular signals. Herein we provide biochemical and genetic
evidence that cross-linking of the B cell receptor (BCR) induces
rapid activation of PLD through a Syk-, Btk- and phospholipase
C (PLC)-Q2-dependent pathway in DT40 cells. Activation of
PLD upon BCR engagement is completely blocked in Syk- or
Btk-deficient cells, but unaffected in Lyn-deficient cells.
Furthermore, in PLC-Q2-deficient cells, BCR engagement failed
to activate PLD. These results demonstrate that Syk, Btk and
PLC-Q2 are essential for BCR-induced PLD activation.
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1. Introduction
Stimulation of surface IgM on B cells (B cell receptor;
BCR) by antigen or anti-IgM antibody initiates a cascade of
biochemical events including protein tyrosine kinase (PTK)
activation, phosphatidylinositol 4,5-bisphosphate (PIP2) hy-
drolysis, and a Ras-mediated pathway. Three distinct families
of non-receptor cytoplasmic PTKs, the Src family PTK Lyn,
Syk, and Btk, have been shown to be activated and have an
important role in BCR signaling [1,2]. It has also been dem-
onstrated that these enzymes mediate the phosphorylation of
at least partially distinct sets of substrates [3,4]. Tyrosine
phosphorylation of Shc, which is an adaptor protein in the
Ras pathway, is regulated by Lyn and Syk [5], while phos-
pholipase C (PLC)-Q2 activation is mediated by Syk and Btk
[4,6]. Tyrosine phosphorylation of PLC-Q2 is responsible for
an increase in its catalytic activity [7]. Activated PLC-Q2 cata-
lyzes the hydrolysis of phosphoinositides, leading to the gen-
eration of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(DG) which, respectively, induce calcium mobilization and
protein kinase C (PKC) activation. However, the downstream
events of phosphoinositide hydrolysis by PLC-Q2 are largely
unknown.
Phospholipase D (PLD) activation in response to a variety
of extracellular signals has been observed in many cells and
tissues. PLD plays an important role in signal transduction
through phosphatidylcholine (PC) hydrolysis to choline and
phosphatidic acid (PA) [8]. The latter is a second messenger
implicated in the regulation of many signaling proteins [9].
Lysophosphatidic acid (LPA) generated through the action
of a speci¢c phospholipase A2 (PLA2) on PA is also becoming
recognized as a major extracellular signal [10]. PA can also be
dephosphorylated by PA phosphohydrolases to DG, which is
an activator of certain isoforms of PKC [11]. Although the
important role of PLD is well documented, the control of
PLD activity is very complex and remains unclear. PKC
[12^14], small GTP-binding protein ADP-ribosylation factor
(ARF) [15] and RhoA [16] are known as PLD activators in
vitro and in vivo. Moreover, many investigations using vari-
ous inhibitors have suggested the involvement of PTK(s) [12],
phosphatidylinositol 3-kinase (PI3-K) [17], trimeric GTP-
binding proteins [12,15,18] and PLC [19,20] in PLD activa-
tion. However, the exact signal pathway involved in the in-
duction of PLD activity remains to be de¢ned.
Recent gene-targeting experiments have established Lyn-,
Syk-, Btk- or PLC-Q2-de¢cient cell lines derived from avian
DT40 B cells [4,6,21], exploiting their unusually high homol-
ogous recombination pro¢ciency. Since we found that PLD
was activated upon BCR engagement in DT40 cells, using
these mutants, a molecular genetic analysis was performed
to identify the pathway involved in BCR signal transduction
ultimately leading to PLD activation. Herein, we provide ge-
netic and biochemical evidence that Syk, Btk and PLC-Q2 are
essential for PLD activation in BCR signaling. This is the ¢rst
report of the involvement of PLD in BCR signaling.
2. Materials and methods
2.1. Materials
The generation of DT40 Lyn3, DT40 Syk3, DT40 Btk3, DT40
PLC-Q23, wild-type syk cDNA-transfected DT40 Syk3 cells (DT40
Syk3/Syk), wild-type btk cDNA-transfected DT40 Btk3 cells (DT40
Btk3/Btk) and wild-type PLC-Q2 cDNA-transfected DT40 PLC-Q23
cells (DT40 PLC-Q23/PLC-Q2) was carried out as described previously
[4,6,21]. Anti-chicken IgM mAb M4 was produced as described pre-
viously [22]. Methyl 2,5-dihydroxycinnamate (erbstatin analog) and
bisindolylmaleimide (BIM) were obtained from Toronto Research,
Inc. and Calbiochem-Novabiochem Corp., respectively. Other chem-
icals were purchased from commercial sources.
2.2. Cell culture and harvesting
DT40 cells were maintained at a cell density of 0.5^1.5U106 cells/ml
as a suspension in RPMI 1640 medium supplemented with 10% (v/v)
fetal calf serum (FCS), 100 U/ml penicillin, and 100 Wg/ml streptomy-
cin in a humidi¢ed 95% air, 5% CO2 atmosphere. For experiments,
cells were collected by centrifugation, washed once in PBS bu¡er, and
then resuspended in FCS-free RPMI 1640 medium, pH 7.4.
2.3. PLD assay
Cells were preincubated with [14C]lysoPC (0.25 WCi/1U107 cells) for
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1 h at 37‡C. The labeled cell suspension (1U106 cells/100 Wl) was
transferred to the reaction mixture (100 Wl) containing ethanol (1%)
and 6 Wg/ml anti-IgM (M4) in FCS-free RPMI 1640 medium, pH 7.4.
The mixture was incubated for additional 30 min at 37‡C. The reac-
tion was stopped by adding 1 ml of ice-cold chloroform/methanol/HCl
1:1:0.006 (v/v). Phase separation and lipid extraction were carried out
as described previously [23]. Samples were spotted on a Silica Gel 60
TLC plate (Merck) and were developed with the upper phase of a
mixture of ethyl acetate/2,2,4-trimethylpentane/acetic acid/water
(13:2:3:10) as a solvent. The radioactive spot of phosphatidylethanol
(PEt) was quanti¢ed using a Fujix Bio Imaging Analyzer, BAS 2000.
PLD activity was expressed as percentage of the radioactivity in
[14C]PEt with the total radioactivity found in all spots in that lane
as 100%.
2.4. Chicken PLD1 cDNA
Total RNA was isolated from DT40 cells by the acid guanidine
thiocyanate method as described previously [24] and reverse tran-
scribed using oligo(dT) primers. Primers used for ampli¢cation of
chicken PLD1 derived from DT40 cell were synthesized as follows:
primer (sense) was 5P-TGGGCTCACCATGAGAA-3P ; primer (anti-
sense) was 5P-GTCATGCCAGGGCATCCGGGG-3P. Ampli¢cation
was carried out at 94‡C for 1 min, 50‡C for 1 min, and 72‡C for
1 min at 30 cycles. Ampli¢ed DNA fragments were labeled with
[32P]dCTP and used in Northern hybridization as probes.
2.5. Northern blot analysis
RNAs were prepared from various types of DT40 cells using the
acid guanidine thiocyanate method as described previously [24]. Total
RNA (20 Wg) was separated in 1.2% formaldehyde gel, transferred to
Hybond-N (Amersham Pharmacia Biotech) membrane and probed
with 32P-labeled chicken PLD1 cDNA.
3. Results and discussion
PLD hydrolyzes phospholipids generating PA and free
choline. However, in the presence of a primary alcohol such
as ethanol, the enzyme catalyzes a transphosphatidylation re-
action that transfers the phosphatidyl moiety to the alcohol,
yielding a phosphatidylalcohol, which is metabolically stable.
This transphosphatidylation reaction is a unique feature of
PLD and constitutes the basis for a sensitive and speci¢c
assay to detect PLD activity. Thus, PLD activation was in-
vestigated in [14C]lysoPC-labeled avian DT40 B cells following
BCR stimulation with anti-IgM (M4) in the presence of etha-
nol. As shown in Fig. 1A, TLC analyses of lipid extracts
derived from BCR-induced DT40 cells exposed to ethanol
revealed a time-dependent increase in the production of PEt.
This result demonstrates the presence of PLD activity in
DT40 cells, which can be stimulated upon BCR engagement.
As shown in Fig. 1B, the formation of PEt can be detected
within 3 min and the total amount of PEt reaches a plateau at
10 min following BCR stimulation. Since BCR engagement
induces the rapid activation of three distinct families of non-
receptor cytoplasmic PTKs, the Src family PTK Lyn, Syk,
and Btk, within 3 min [4,6], subsequently PLD activation
may occur following the activation of these PTKs. As shown
in Fig. 1C, the dose dependence of M4-mediated PEt forma-
tion demonstrated that PLD was maximally activated follow-
ing stimulation with M4 at concentration of 4^10 Wg/ml, a
range suboptimal for the activation of PTKs [4,6]. Thus, we
hypothesized that BCR-induced PLD activation may be de-
pendent on PTK activation. Indeed, in a preliminary experi-
ment, a PTK inhibitor, erbstatin analog, drastically reduced
BCR-induced PLD activation in DT40 B cells (data not
shown).
To further investigate which PTK(s) is (are) involved in
PLD activation, we have analyzed the BCR-induced PLD
activation in each of the DT40 B cells de¢cient in Lyn, Syk
and Btk [4,6]. As shown in Fig. 2A, PLD activation upon
BCR engagement was completely blocked in DT40 Syk3,
DT40 Btk3 cells and restored in DT40 Syk3/Syk and DT40
Btk3/Btk cells. Unexpectedly, in DT40 Lyn3 cells, PLD acti-
vation, following BCR stimulation, was found to be unaf-
fected. Through these PTKs, both the Ras pathway and the
PLC-Q2 pathway are known to be major downstream events in
BCR signaling. Since it has been suggested that the BCR-
induced Ras pathway is blocked in Lyn-de¢cient cells [5,25],
it appears that PLD activation is independent of the Src fam-
ily PTK Ras pathway. This striking point contrasts with the
previous observation that in ¢broblast cells v-Src activates
PLD through Ras [26]. On the other hand, PLC-Q2 activity
is regulated by Syk and Btk through their concerted actions,
and the activation of PLC-Q2 upon BCR engagement is shown
to occur normally in Lyn-de¢cient cells, but completely abol-
ished in Syk- or Btk-de¢cient cells [4,6]. Together, these ob-
servations prompted us to analyze PLD activation in PLC-Q2-
de¢cient cells. As shown in Fig. 2B, DT40 PLC-Q23 cells,
BCR engagement failed to activate PLD and was restored
in DT40 PLC-Q23/PLC-Q2 cells. These results demonstrated
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Fig. 1. PLD activation in DT40 cells following BCR stimulation.
A: TLC analysis pattern of lipid extracts derived from anti-IgM
(M4)-stimulated DT40 cells. B: Radioactivity in the PEt fraction in
A was determined. Metabolically labeled wild-type DT40 cells with
[14C]lysoPC were incubated for the indicated times (min) at 37‡C
with (b) or without (a) 6 Wg/ml M4. C: Incubation for 30 min at
37‡C with indicated dose of M4. PLD activity was measured as de-
scribed in Section 2. 0 min: M4 or vehicle was added after extrac-
tion by chloroform/methanol/HCl 1:1:0.006 (v/v). Results are the
means þ S.D. of ¢ve independent experiments.
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that Syk, Btk, but not Lyn, and subsequent activation of
PLC-Q2 are required in the signaling pathway from the BCR
to the induction of PLD activation. Since Northern blot anal-
ysis indicated no relation between PLD activities and PLD1
mRNA levels, the blocking of PLD activity is not due to a
di¡erence of PLD1 expression (Fig. 2C).
Activated PLC-Q2 catalyzes the hydrolysis of PIP2, leading
to calcium mobilization and PKC activation. To investigate
whether PKC activation is involved in PLD activation in BCR
signaling, the e¡ect of the speci¢c PKC inhibitor BIM on
BCR-induced PLD activation was examined. As shown in
Fig. 3, at 10 WM, BIM inhibited phorbol ester-induced PLD
activation in DT40 cells (data not shown), and drastically
inhibited M4-induced PLD activation. Indeed, this result is
consistent with previous observation that at 1^10 WM, BIM
e⁄ciently blocks EGF-induced PLD activation in intact Swiss
3T3 cells [27]. Although it is known that the conventional
K- and L-isozymes of PKC activate PLD without kinase ac-
tivities in vitro [14], our result indicates that PKC activities
are required for PLD activation in intact DT40 cells, suggest-
ing that PKC may modulate PLD activity without direct in-
teraction. Recently, it has been reported that PKCW was acti-
vated upon BCR cross-linking [28], and that PKCL-de¢cient
mice showed impaired humoral immune responses in their B
cells [29]. These ¢ndings imply that certain PKC isozymes are
functionally important in BCR signaling.
In other cell systems, the PTK-dependent pathway involved
in PLD activation is still controversial. For instance, PLD
activation induced by the stimulation of the PDGF receptor
has been suggested to be downstream of PDGF-mediated ty-
rosine phosphorylation of PLC-Q, PIP2 hydrolysis and PKC
activation [20]. In the case of the T cell receptor (TCR), an-
other antigen receptor similar to the BCR, TCR-induced PLD
activation has been shown to be abrogated by PTK and PKC
inhibitors [30]. These observations support the PTK-PLC-Q-
dependent pathway for PLD activation. On the other hand,
Reid et al. found substantial activation of PLD activity in
response to concentrations of anti-CD3 which led to cell acti-
vation, but undetectable levels of IP3 generation, suggesting
that at least one form of CD3-induced PLD activation is PIP2
hydrolysis-independent in Jurkat T cells [31]. Moreover,
Koike et al. found that treatment of rat peritoneal mast cells
with stem cell factor activates PLD in the absence of IP3
formation [32]. Melendez et al. also observed that FcQ recep-
tor I-induced PLD activation is not coupled to PLC in the
monocyte [33]. Therefore, it appears that PLD activation may
result from many di¡erent mechanisms, and our results genet-
ically demonstrate the Syk-, Btk- and PLC-Q2-dependent acti-
vation of PLD in BCR signaling.
Regarding the function of PLD in BCR signaling, PLD has
been proposed to play a key role in the transduction of pro-
liferative responses of a wide range of mitogens and growth
factors. PA, a product of PLD, has been shown to promote
the induction of the proto-oncogenes c-fos and c-myc [34].
Interestingly, the induction of c-myc following BCR engage-
ment was observed in wild and Lyn-de¢cient DT40 cells, but
not in Syk- or PLC-Q2-de¢cient DT40 cells [35]. Furthermore,
very recently, Gilbert et al. reported that mitogenic stimula-
tion of BCR is coupled to a novel non-PC-hydrolyzing PLD
(phosphatidylinositol-speci¢c PLD) activity and that this PLD
activation may play a role in mature B cell survival and pro-
liferation [36]. Indeed, butanol, a PLD inhibitor, induced
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Fig. 3. Inhibition of BCR-induced PLD activation by the PKC-
speci¢c inhibitor bisindolylmaleimide. Labeled DT40 cells with
[14C]lysoPC were preincubated for 20 min at 37‡C with bisindolyl-
maleimide as indicated, followed by incubation for 30 min at 37‡C
with (b) or without (a) 6 Wg/ml anti-IgM (M4). PLD activity was
measured as described in Section 2. Results are the means þ S.D. of
¢ve separate experiments.
Fig. 2. BCR-induced PLD activation and Northern blot analysis for
PLD1 in various DT40 mutants. A: PLD activation in wild-type
(WT), Lyn3, Syk3, Syk3/Syk, Btk3, Btk3/Btk DT40 cells. These
cells were labeled with [14C]lysoPC and incubated for 30 min at
37‡C with (hatched bar) or without (open bar) 6 Wg/ml anti-IgM
(M4). B: PLD activation in wild-type (WT), PLC-Q23 (PLCQ3),
PLC-Q23/PLC-Q2 (PLCQ3/PLCQ) DT40 cells. PLD activity was
measured as described in Section 2. Results are the means þ S.D. of
¢ve separate experiments. C: mRNA expression was analyzed by
Northern blot analysis using chicken cDNA probe for PLD1 (top)
or L-actin (bottom).
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apoptosis in DT40 cells (data not shown). Thus, these data
suggest that PLD activity plays an important role in the BCR-
induced survival, protection from apoptosis and proliferation.
However, it is possible that BCR-induced PLD activation
transduces early signals associated with BCR-mediated
growth arrest or apoptosis in immature B cells since the
vast majority of DT40 cells are programmed for cell death
by apoptosis. The exact role of PLD remains unclear.
We are currently attempting to establish a PLD-de¢cient
cell line by gene targeting in DT40 B cells. The genetic anal-
ysis of this mutant will provide a major tool in the physio-
logical investigation of the functions of PLD.
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